-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Caris Life Sciences, Lowers Price Target to $30

Benzinga·05/08/2026 18:28:09
Listen to the news
JP Morgan analyst Casey Woodring maintains Caris Life Sciences (NASDAQ:CAI) with a Overweight and lowers the price target from $35 to $30.